AccessPak for HIV PEP Expanded with Viracept and Blinatumomab Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Blinatumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: blinatumomab
Brand name: Blincyto
Synonyms: Blinatumomab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Blincyto
- AccessPak for HIV PEP Expanded with Viracept-Blisovi 24 Fe
- AccessPak for HIV PEP Expanded with Viracept-Blisovi 24 FE birth control
- AccessPak for HIV PEP Expanded with Viracept-Blisovi Fe 1.5/30
- AccessPak for HIV PEP Expanded with Viracept-Blisovi Fe 1/20
- AccessPak for HIV PEP Expanded with Viracept-Blocadren
- Blinatumomab Intravenous-Accolate
- Blinatumomab Intravenous-Accretropin
- Blinatumomab Intravenous-Accucaine
- Blinatumomab Intravenous-AccuHist Drops
- Blinatumomab Intravenous-AccuHist PDX Drops
- Blinatumomab Intravenous-AccuHist PDX Syrup